US Payor Guidance on Market Access and Clinical Trial Design for Digital Therapeutics in Mental Health

Digital Therapeutic Client needed to understand payer perspectives on Digital Therapeutic (DTx) clinical and economic value based on the product profile

- Conducted competitive market landscape analysis of DTx industry - Literature review of pricing and coverage of current depression treatments - Identified that Payors not fully aware of DTx potential and reimbursement dynamics

- Developed research design that educated payors on DTx by laying the foundation of clinical science followed by digital execution - Enhanced market research methodology by demonstrating Clinical Trial design flow and end point validation

- Conducted double-blinded interviews with a panel of payers and analyzed the interview responses to provide perceptions on the therapeutic and economic value followed by a set of recommendations - Developed Screener, Discussion Guide, Target Product profile and CT design - Developed Payor segmentation to DTx as Skeptics, Watchful Waiters and Early Adopters

- Client Clinical team proceeded with robust set of trial design priorities and recommendations - Market Access team confident with a strong foundation on payer needs and expectations from product